Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- ...
Researchers evaluated the impact of different treatment modalities in the prevention of psoriatic arthritis (PsA). Biological agents were found more effective than methotrexate in preventing psoriatic ...
"We believe that prescribing this combination in routine practice is viable when combined with shared decision-making and strict monitoring of side effects," write Michelle L. M. Mulder, MD, of the ...
Findings of a phase 2b study indicated that use of tildrakizumab was associated with significant improvements in joint and skin manifestations of patients with psoriatic arthritis (PsA), although ...
For patients with psoriatic arthritis, bimekizumab was more effective for treating cutaneous symptoms compared with many other available treatments and ranked highly among currently approved ...
CHICAGO—PSA levels at the time of initial screening among men aged 44-50 years can accurately predict the risk that a man will die from prostate cancer (PCa) or develop metastatic PCa up to 30 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results